Cargando…

The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson’s disease

BACKGROUND: It is suggested that neuroinflammation, in which activated microglial cells play a relevant role, contributes to the development of Parkinson’s disease (PD). Consequently, the modulation of microglial activation is a potential therapeutic target to be taken into account to act against th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rabaneda-Lombarte, Neus, Serratosa, Joan, Bové, Jordi, Vila, Miquel, Saura, Josep, Solà, Carme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025338/ https://www.ncbi.nlm.nih.gov/pubmed/33823877 http://dx.doi.org/10.1186/s12974-021-02132-z

Ejemplares similares

Parkinsonian neurotoxicants impair the anti-inflammatory response induced by IL4 in glial cells: involvement of the CD200-CD200R1 ligand-receptor pair
por: Rabaneda-Lombarte, Neus, et al.
Publicado: (2020)

Parkinsonian Neurotoxins Impair the Pro-inflammatory Response of Glial Cells
por: Rabaneda-Lombarte, Neus, et al.
Publicado: (2019)

Altered expression of the immunoregulatory ligand-receptor pair CD200-CD200R1 in the brain of Parkinson’s disease patients
por: Rabaneda-Lombarte, Neus, et al.
Publicado: (2022)

Inhibition of CD200R1 expression by C/EBP beta in reactive microglial cells
por: Dentesano, Guido, et al.
Publicado: (2012)

Alterations in CD200-CD200R1 System during EAE Already Manifest at Presymptomatic Stages
por: Valente, Tony, et al.
Publicado: (2017)

Myeloid C/EBPβ deficiency reshapes microglial gene expression and is protective in experimental autoimmune encephalomyelitis
por: Pulido-Salgado, Marta, et al.
Publicado: (2017)

Modelling Neuroinflammation In Vitro: A Tool to Test the Potential Neuroprotective Effect of Anti-Inflammatory Agents
por: Gresa-Arribas, Núria, et al.
Publicado: (2012)

Microglial cGAS drives neuroinflammation in the MPTP mouse models of Parkinson's disease
por: Ma, Chunmei, et al.
Publicado: (2023)

CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease
por: Zhang, Shi, et al.
Publicado: (2011)

Pro-inflammatory gene expression and neurotoxic effects of activated microglia are attenuated by absence of CCAAT/enhancer binding protein β
por: Straccia, Marco, et al.
Publicado: (2011)

A C-terminally truncated form of β-catenin acts as a novel regulator of Wnt/β-catenin signaling in planarians
por: Su, Hanxia, et al.
Publicado: (2017)

DAP12 and CD11b contribute to the microglial-induced death of dopaminergic neurons in vitro but not in vivo in the MPTP mouse model of Parkinson’s disease
por: Kinugawa, Kiyoka, et al.
Publicado: (2013)

The role of N-glycosylation of CD200-CD200R1 interaction in classical microglial activation
por: Liu, Chao, et al.
Publicado: (2018)

Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease
por: Vijitruth, Rattanavijit, et al.
Publicado: (2006)

RIPK1 Regulates Microglial Activation in Lipopolysaccharide-Induced Neuroinflammation and MPTP-Induced Parkinson’s Disease Mouse Models
por: Kim, Do-Yeon, et al.
Publicado: (2023)

Microglial cells in astroglial cultures: a cautionary note
por: Saura, Josep
Publicado: (2007)

Isobavachalcone Attenuates MPTP-Induced Parkinson's Disease in Mice by Inhibition of Microglial Activation through NF-κB Pathway
por: Jing, Haoran, et al.
Publicado: (2017)

The CD200-CD200 Receptor Inhibitory Axis Controls Arteriogenesis and Local T Lymphocyte Influx
por: van den Borne, Pleunie, et al.
Publicado: (2014)

CD200 is up-regulated in R6/1 transgenic mouse model of Huntington's disease
por: Comella Bolla, Andrea, et al.
Publicado: (2019)

Idebenone Alleviates Neuroinflammation and Modulates Microglial Polarization in LPS-Stimulated BV2 Cells and MPTP-Induced Parkinson’s Disease Mice
por: Yan, Aijuan, et al.
Publicado: (2019)

CD200R/Foxp3-mediated signalling regulates microglial activation
por: Yi, Min-Hee, et al.
Publicado: (2016)

The CD200–CD200R1 Inhibitory Signaling Pathway: Immune Regulation and Host–Pathogen Interactions
por: Vaine, Christine A., et al.
Publicado: (2014)

Restoration of intestinal function in an MPTP model of Parkinson’s Disease
por: Ellett, L. J., et al.
Publicado: (2016)

Author Correction: CD200R/Foxp3-mediated signalling regulates microglial activation
por: Yi, Min-Hee, et al.
Publicado: (2020)

Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients
por: Recasens, Ariadna, et al.
Publicado: (2018)

Chronic Infection Drives Expression of the Inhibitory Receptor CD200R, and Its Ligand CD200, by Mouse and Human CD4 T Cells
por: Caserta, Stefano, et al.
Publicado: (2012)

Autotransphntation of the Cervical Sympathetic Ganglion into Monkeys With MPTP-Induced Parkinsonism
por: Itakura, Toru, et al.
Publicado: (1992)

Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
por: Klemann, Cornelius J. H. M., et al.
Publicado: (2015)

Parkinson’s disease model in zebrafish using intraperitoneal MPTP injection
por: Omar, Noor Azzizah, et al.
Publicado: (2023)

Cdk5 Inhibitory Peptide Prevents Loss of Dopaminergic Neurons and Alleviates Behavioral Changes in an MPTP Induced Parkinson’s Disease Mouse Model
por: He, Rongni, et al.
Publicado: (2018)

CD200-CD200R1 inhibitory signaling prevents spontaneous bacterial infection and promotes resolution of neuroinflammation and recovery after stroke
por: Ritzel, Rodney M., et al.
Publicado: (2019)

Artemisinin exerts a protective effect in the MPTP mouse model of Parkinson's disease by inhibiting microglial activation via the TLR4/Myd88/NF‐KB pathway
por: Lv, Jing, et al.
Publicado: (2023)

The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson’s disease
por: Mustafa, S., et al.
Publicado: (2016)

Social behavioral changes in MPTP-treated monkey model of Parkinson's disease
por: Durand, Elodie, et al.
Publicado: (2015)

Pretreatment of caffeine leads to partial neuroprotection in MPTP model of Parkinson's disease
por: Bagga, Puneet, et al.
Publicado: (2016)

The Neuroprotective Effects of Cinnamic Aldehyde in an MPTP Mouse Model of Parkinson’s Disease
por: Bae, Woom-Yee, et al.
Publicado: (2018)

Dynamic Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson's Disease
por: Huang, Dongping, et al.
Publicado: (2017)

The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson’s disease
por: Schwenkgrub, Joanna, et al.
Publicado: (2017)

Preparation and Neuroprotective Activity of Glucuronomannan Oligosaccharides in an MPTP-Induced Parkinson’s Model
por: Liu, Yingjuan, et al.
Publicado: (2020)

Transplantation in the nonhuman primate MPTP model of Parkinson's disease: update and perspectives
por: Wianny, Florence, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qvmadgv2ngftgf0s8pkdf5ksjr